Skip to main content
This page, MAP resources, is part of
This page, MAP resources, is offered by

MAP resources

Advisories, guides, and regulations for the Medication Administration Program (MAP)
Skip table of contents

Table of Contents

Advisories

MAP Policy 10-3 Controlled Substance Count  
MAP Policy No. 01-2 Criteria for Site Registration with DPH 
Acceptable MAR Codes (PDF 285.35 KB)
Circular #DCP 20-3-110: Medication Administration Program (MAP) - Patient Prescribing Directives 
Naloxone Use 
Methadone Take Home Doses in an Storm or Emergency 
On-Line References 
New MAP Site Checklist 
Transportation of Medication (to and from) MAP Site 
MAP Certification Process 
Suspected Drug Tampering-MAP Sites 
Hospice Policy 16-2 Exception to Other Policies 
Medication Occurrence Reporting 
Epinephrine Administration via Auto-Injector Device MAP Sites-Competency Evaluation Tool 
Valid Health Care Provider Orders - MAP Sites (DOCX 55.03 KB)
Valid Health Care Provider Orders - MAP Sites (PDF 200.93 KB)

Guides and brochures

Countable Controlled Substance Book Retention Guidelines (PDF 58.13 KB)
Countable Controlled Substance Book Retention Guidelines (DOCX 21.06 KB)
MAP brochure (PDF 199.28 KB)
MAP brochure (DOC 1.29 MB)

Regulations

View MAP regulations 

Related materials

AR 9401 The Role of the Licensed Nurse in the Department of Public Health Medication Administration Program (DOCX 11.39 KB)
June 9, 2016 Memo - Revised AR 9401: Role of the Licensed Nurse as Trainer or Consultant for DPH MAP (DOC 55.5 KB)
Advisory rulings for the Board of Registration in Nursing 
News and updates for the Board of Registration in Nursing 
D&S Diversified Technologies Testing information 

Notices

Notice of Rescission of MAP High Alert Medication (combination drug product buprenorphine hydrochloride and naloxone (brand name Suboxone) Policy 08-7 (DOCX 55 KB)
Notice of Rescission of MAP High Alert Medication (combination drug product buprenorphine hydrochloride and naloxone (brand name Suboxone) Policy 08-7 (PDF 131.77 KB)
Notice of Rescission of MAP Hospice Policies 16-2 and 16-3 (PDF 265.34 KB)
Notice of Rescission of MAP Hospice Policies 16-2 and 16-3 (DOC 47 KB)
Notice of Revised Form: Gastrostomy or Jejunostomy Management Form (DOC 101.5 KB)

Waiver Request

MAP Waiver Request Template (DOC 40 KB)
MAP Waiver Request Template (PDF 10.73 KB)
Feedback